Status:
ACTIVE_NOT_RECRUITING
Host and Bacterial Mechanisms During Cystic Fibrosis Pulmonary Exacerbations
Lead Sponsor:
National Jewish Health
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
18+ years
Brief Summary
Cystic fibrosis pulmonary exacerbations (CF PEx) vary greatly in their severity, their pathogens, and their treatment responses. A failure to return to baseline lung function after treatment may be du...
Eligibility Criteria
Inclusion
- CF patients 18 years or older
- hospitalized for IV treatment of an acute pulmonary exacerbation
- not on investigational drugs
- who can provide written consent and are willing to comply with study procedure
Exclusion
- • the presence of a condition or abnormality that, in the opinion of the Principal Investigator, would compromise the safety of the patient or the quality of the data.
Key Trial Info
Start Date :
January 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04354038
Start Date
January 7 2020
End Date
December 1 2026
Last Update
September 30 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Jewish Health
Denver, Colorado, United States, 80206